WANJIA GROUP

401
0.1080.92% ( -0.001 )
Delay Closed: Nov 16, 16:08:00

Valuation

Current ValuationThe current P/E ratio is -12.36, within the reasonable range, cheaper than 40.61% of the time in the past 1 years, and the industry ranks 19/22, the industry Median 6.34.

-12.36xP/E
Stock priceHK$0.11Earnings per shareHK$-0.01

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.34x
05101520

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.34x
0x10x20x30x40x50x
P/E ratio
Name/Symbol
02427HKGUANZE MEDICAL
-22.61x--HK$1.87B
02656HK160 HEALTH
-15.22x--HK$906.30M
01931HKETHK LABS INC.
-6.16x--HK$529.42M
00673HKCHINA HEALTH
-9.12x--HK$436.95M
02211HKUNI HEALTH
-17.15x--HK$403.49M
09955HKCLOUDR
-0.54x89.93%HK$251.83M
00718HKTAI UNITED HOLD
-0.39x--HK$147.00M
00401HKWANJIA GROUP
-12.36x--HK$121.89M
08156HKSINOPHARM TECH
-10.61x--HK$96.96M
02984HKNEW RAY MED-8K
-4.53x--HK$73.23M
00574HKPASHUN INT'L
-2.04x--HK$35.83M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.